Literature DB >> 11208765

Differential Distribution of Bradykinin B(2) Receptors in the Rat and Human Cardiovascular System.

Carlos D. Figueroa1, Alejandra Marchant, Ulises Novoa, Ulrich Förstermann, Kurt Jarnagin, Bernward Schölkens, Werner Müller-Esterl.   

Abstract

-Bradykinin, a major vasodilator peptide, plays an important role in the local regulation of blood pressure, blood flow, and vascular permeability; however, the cellular distribution of the major bradykinin B(2) receptor in the cardiovascular system is not precisely known. Immunoblot analysis with an anti-peptide antibody to the bradykinin B(2) receptor or chemical cross-linkage with [(125)I]Tyr(0)-bradykinin revealed a band of 69+/-3 kDa at varying intensity in the homogenates of the endothelium and tunica media of the rat aorta and endocardium. Immunostaining showed that the B(2) receptor is abundant in the endothelial linings of the aorta, other elastic arteries, muscular arteries, capillaries, venules, and large veins, where it localizes preferentially to the luminal face of the endothelial cells. In marked contrast, small arterioles (ie, the principal blood-pressure regulating vessels) of the mesenterium, heart, urinary bladder, brain, salivary gland, and kidney had a different staining pattern in which B(2) receptor was prominent in the perivascular smooth muscle cells of the tunica media. A similar distribution pattern was found in mouse as well as in human tissues, indicating that the particular distribution pattern of the B(2) receptor in arterioles is not a species-specific phenomenon. During development, the distribution of B(2) receptor in the heart changes; for example, in the heart of newborn rats, the B(2) receptor was abundant in the myocardium, whereas in the adult heart, the receptor was present in the endocardium of atria, atrioventricular valves, and ventricles but not in the myocardium. Thus, B(2) receptors are localized differentially in different parts of the cardiovascular system: the arterioles have smooth muscle-localized B(2) receptors, and large elastic vessels have endothelium-localized receptors.

Entities:  

Year:  2001        PMID: 11208765     DOI: 10.1161/01.hyp.37.1.110

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Are blood vessels a target to treat lower urinary tract dysfunction?

Authors:  Martin C Michel; Russ Chess-Williams; Sharath S Hegde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-31       Impact factor: 3.000

2.  Tissue kallikrein and bradykinin B2 receptor in human uterus in luteal phase and in early and late gestation.

Authors:  G Valdés; A M Germain; J Corthorn; C Chacón; C D Figueroa; W Müller-Esterl
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

3.  ACE inhibition enhances bradykinin relaxations through nitric oxide and B1 receptor activation in bovine coronary arteries.

Authors:  Kathryn M Gauthier; Cody J Cepura; William B Campbell
Journal:  Biol Chem       Date:  2013-09       Impact factor: 3.915

Review 4.  Polarized Proteins in Endothelium and Their Contribution to Function.

Authors:  Abigail G Wolpe; Claire A Ruddiman; Phillip J Hall; Brant E Isakson
Journal:  J Vasc Res       Date:  2021-01-27       Impact factor: 1.934

5.  Activity of Bradykinin B2 Receptor Is Regulated by Long-Chain Polyunsaturated Fatty Acids.

Authors:  Jose Candelario; Mirianas Chachisvilis
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

6.  Acute and subchronic exposure to air particulate matter induces expression of angiotensin and bradykinin-related genes in the lungs and heart: Angiotensin-II type-I receptor as a molecular target of particulate matter exposure.

Authors:  Octavio Gamaliel Aztatzi-Aguilar; Marisela Uribe-Ramírez; José Antonio Arias-Montaño; Olivier Barbier; Andrea De Vizcaya-Ruiz
Journal:  Part Fibre Toxicol       Date:  2015-06-26       Impact factor: 9.400

7.  Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells.

Authors:  Oula K Dagher; Miran A Jaffa; Aïda Habib; Fuad N Ziyadeh; Ayad A Jaffa
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

Review 8.  Human tissue kallikrein in the treatment of acute ischemic stroke.

Authors:  Michelle Alexander-Curtis; Rick Pauls; Julie Chao; John J Volpi; Philip M Bath; Todd A Verdoorn
Journal:  Ther Adv Neurol Disord       Date:  2019-01-20       Impact factor: 6.570

9.  Transcriptome Analysis Reveals Differential Gene Expression between the Closing Ductus Arteriosus and the Patent Ductus Arteriosus in Humans.

Authors:  Junichi Saito; Tomoyuki Kojima; Shota Tanifuji; Yuko Kato; Sayuki Oka; Yasuhiro Ichikawa; Etsuko Miyagi; Tsuyoshi Tachibana; Toshihide Asou; Utako Yokoyama
Journal:  J Cardiovasc Dev Dis       Date:  2021-04-16

10.  Streptococcus gallolyticus subsp. gallolyticus endocarditis isolate interferes with coagulation and activates the contact system.

Authors:  Julia Isenring; Juliane Köhler; Masanobu Nakata; Marcus Frank; Christoph Jans; Pierre Renault; Camille Danne; Shaynoor Dramsi; Bernd Kreikemeyer; Sonja Oehmcke-Hecht
Journal:  Virulence       Date:  2017-12-26       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.